date:Dec 14, 2022
shares in Chr. Hansen than what is offered to other shareholders.
Market growth opportunities
Novozymes estimates the current market for biological solutions like those offered by the two companies to be around 15 billion (US$15.8 billion) and expanding, with the World Economic Forum predicting a three-fold expansion by 2040.
With this proposed combination, we are jointly creating a leading biosolutions partner dedicated to securing a healthy planet and a more sustainable future, underscores D